HomeVenture Capital

Venture Capital

Venture Capital

BayPine to Acquire CenExel, Expanding Investment in Clinical Research

Life Sciences Times - April 14, 2025

Venture Capital

Foreign Direct Investment in India’s Pharma Sector Crosses $2.3 Billion in FY 2024-25

Life Sciences Times - April 13, 2025

Venture Capital

illumicell AI Secures $2M to Revolutionize Male Fertility Diagnostics with Real-Time AI

Life Sciences Times - April 10, 2025

Venture Capital

Symphonic Capital Launches $13.5M Fund to Back Startups Bridging Health and Wealth Gaps

Life Sciences Times - April 10, 2025

Venture Capital

Caris Life Sciences Secures $168 Million in Funding to Accelerate Precision Medicine Innovation

Life Sciences Times - April 10, 2025

Venture Capital

Vaxess Secures $9 Million to Advance Needle-Free Drug Delivery Platform

Life Sciences Times - April 10, 2025 0

Venture Capital

SecondWave Systems Secures $7M to Advance Noninvasive Ultrasound Therapy for Inflammatory Diseases

Life Sciences Times - April 9, 2025 0

Venture Capital

Solu Therapeutics Raises $41M in Series A Round, Doses First Patient in Clinical Trial for Novel CMML Therapy

Life Sciences Times - April 9, 2025 0

Venture Capital

Rescale Raises $115 Million to Expand AI-Powered Digital Engineering Platform

Life Sciences Times - April 7, 2025 0

Venture Capital

Biotech Startup RayThera Secures $110 Million to Advance Immunology Drug Pipeline

Life Sciences Times - April 4, 2025 0

Venture Capital

Corundum Systems Biology Expands Opens Cambridge Office, Strengthening Ties to Biotech Innovation

Life Sciences Times - April 3, 2025 0

Venture Capital

AIRNA Secures $155 Million in Oversubscribed Series B Funding to Advance RNA Editing Therapies

Life Sciences Times - April 1, 2025 0

Venture Capital

Insilico Medicine Secures $110 Million in Series E Funding to Advance AI-Driven Drug Discovery

Life Sciences Times - April 1, 2025 0

Venture Capital

Novotech Secures Major Investment from GIC, Temasek, and TPG to Drive Global Expansion

Life Sciences Times - March 31, 2025 0

Venture Capital

Epicrispr Biotechnologies Secures $68 Million Series B

Life Sciences Times - March 26, 2025 0

Venture Capital

Character Biosciences Raises $93 Million Series B to Advance Precision Medicine for Progressive Eye Diseases

Life Sciences Times - March 25, 2025 0

Venture Capital

Venture Capital Fundraising in Healthcare Remains Healthy

Life Sciences Times - March 21, 2025 0

12 3...96 Page 1 of 96

Most Read

$30 Million in Medical Debt Abolished for Residents of Eastern Massachusetts

April 14, 2025

Pfizer Halts Development of Oral Weight Loss Drug Danuglipron

April 14, 2025

$5M Gift to Support Scholarships at New ASU Medical School

April 14, 2025

Harvard Bioscience Announces CFO Transition

April 14, 2025

EDITOR PICKS

Novartis to Invest $23 Billion in Expanding U.S. Manufacturing and Research Footprint

April 13, 2025

Congressional Commission Calls for $15 Billion Boost to U.S. Biotechnology Sector

April 12, 2025

FDA Unveils Historic Shift Away from Animal Testing for Drug Development

April 12, 2025

THIS WEEK'S STORIES

Turbett Surgical Secures FDA Clearance for Upgraded Instrument Pod Line

April 11, 2025

Soleus Capital Pushes for Theratechnologies Sale

April 13, 2025

Bipartisan Lawmakers Unveil National Biotechnology Initiative to Bolster U.S. Innovation and Security

April 10, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Contact us: [email protected]

FOLLOW US

© Newspaper WordPress Theme by TagDiv